Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775
Eisai Inc.
Vicky Makker; Nicoletta Colombo; Antonio Casado Herráez; Bradley J Monk; Helen Mackay; Alessandro D Santin; David S Miller; Richard G Moore; Sally Baron-Hay; Isabelle Ray-Coquard; Kimio Ushijima; Kan Yonemori; Yong Man Kim; Eva M Guerra Alia; Ulus A Sanli; Steven Bird; Robert Orlowski; Jodi McKenzie; Chinyere Okpara; Gianmaria Barresi; Domenica Lorusso